COHERUS BIOSCIENCES INC. - COMMON STOCK

Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023

30 окт 2023 18:00:00 Источник Nasdaq GlobeNewswire

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

27 окт 2023 15:07:20 Источник Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

24 окт 2023 19:41:27 Источник Nasdaq GlobeNewswire

Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

14 окт 2023 12:30:00 Источник Nasdaq GlobeNewswire

Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™

05 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire

CIMERLI® (ranibizumab-eqrn) Sales Exceed 100,000 Doses in First Year of Launch

04 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire

Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day

02 окт 2023 09:00:00 Источник Nasdaq GlobeNewswire

Coherus Announces Three Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

27 сен 2023 09:10:29 Источник Nasdaq GlobeNewswire

FDA Issues Complete Response Letter (CRL) for UDENYCA® ONBODY™ Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-Party Filler; Coherus Also Announces Completion of Toripalimab FDA Inspections

25 сен 2023 08:30:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

22 сен 2023 21:00:00 Источник Nasdaq GlobeNewswire

Coherus Completes Surface Oncology Acquisition

08 сен 2023 09:05:40 Источник Nasdaq GlobeNewswire

Coherus BioSciences to Participate at Upcoming September Investor Conferences

01 сен 2023 16:01:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

22 авг 2023 17:35:22 Источник Nasdaq GlobeNewswire

Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights

02 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023

26 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

21 июл 2023 17:30:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors

20 июл 2023 16:04:53 Источник Nasdaq GlobeNewswire

Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™

13 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.

03 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants

26 июн 2023 21:08:00 Источник Nasdaq GlobeNewswire